EVOKE PHARMA INC - COM (EVOK)

CUSIP: 30049G104

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / COM
Total 13F shares
404,806
Share change
-50,062
Total reported value
$2,226,367
Price per share
$5.49
Number of holders
11
Value change
-$402,087
Number of buys
4
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 30049G104?
CUSIP 30049G104 identifies EVOK - EVOKE PHARMA INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EVOKE PHARMA INC - COM (EVOK) as of Q3 2014

As of 30 Sep 2014, EVOKE PHARMA INC - COM (EVOK) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 404,806 shares. The largest 10 holders included Opaleye Management Inc., VANGUARD GROUP INC, CAM Group Holding A/S, LMR Partners LLP, GEODE CAPITAL MANAGEMENT, LLC, BANK OF AMERICA CORP /DE/, Ground Swell Capital, LLC, Tower Research Capital LLC, BlackRock Investment Management, LLC, and BARCLAYS PLC. This page lists 11 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.